Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinoma

by Toh, H.C., Chen, P.-J., Carr, B.I., Knox, J.J., Gill, S., Ansell, P., McKeegan, E.M., Dowell, B., Pedersen, M., Qin, Q., Qian, J., Scappaticci, F.A., Ricker, J.L., Carlson, D.M., Yong, W.P.
Published 2014